Skip to main content
Use this button to show the site search bar.
Prescribing Companion
Prescribing Companion
Search for toolkits, guidelines and other information:
Search
Menu
Toolkits
Bangladesh
Bhutan
Eswatini
Ghana
India
Indonesia
Kenya
Laos
Malawi
Nepal
Nigeria
Pakistan
Papua New Guinea
Senegal
Sierra Leone
Sri Lanka
Tanzania
Timor-Leste
Uganda
Vietnam
Zambia
Zimbabwe
Contact Us
About
SPARC Prescribing Companion App FAQs
Notifications
Disclaimer
Home
Bangladesh
Other Common Clinical Conditions
Tuberculosis (National Guideline and Operational Manual)
Back
5. Treatment of Tuberculosis
5.10 Management of new smear-positive cases after interrupting treatment
5.10 Management of new smear-positive cases after interrupting treatment
exp date isn't null, but text field is
*TALF= Treatment after loss to follow-up
Bangladesh
Infections and Infectious Diseases Prescribing
Other Common Clinical Conditions
Hypertension (National Guideline)
Diabetes Mellitus (National Guideline)
Tuberculosis (National Guideline and Operational Manual)
Abbreviation and Acronyms
1. Introduction
2. General Information about Tuberculosis
3. Case Finding of Tuberculosis
4. Diagnosis of Tuberculosis
5. Treatment of Tuberculosis
Treatment of Tuberculosis
5.1 Aims of treatment
5.2 Basic Principles of TB treatment
5.3 When should the treatment of tuberculosis be started
5.4 Standardized Regimens
5.5 Treatment category for all TB patients
5.7 Monitoring of Treatment
5.8 Treatment for extra-pulmonary TB patients
5.9 Newer regimen for drug-susceptible TB
5.10 Management of new smear-positive cases after interrupting treatment
5.11 Treatment outcome of TB patients
5.12 Referral and transfer of patients
6. TB in Special Situations
7. Adverse Effect Management
8. Tuberculosis in Children
9. Drug-Resistant Tuberculosis
10. Treatment delivery and Adherence
11. Contact Investigation
12. Latent TB Infection
13. TB/HIV Co-Infection
14. TB and Nutrition
15. TB Infection Prevention and Control (IPC)
16. Advocacy Communication and Social Mobilization (ACSM)
17. Public Private Mix (PPM) For TB Control
18. Supply of Drugs, Laboratory Consumables and Documentation Materials
19. Supervision, Monitoring and Evaluation
20. Recording and Reporting
21. COVID-19 and its impact on TB
Annex
Chikungunya Fever (National Guideline)
Animal Bite Management (National Guideline)
Malaria (Revised Treatment Regimen)
Dengue Syndrome (National Guideline)
Infant and Young Child Feeding (IYCF)
Tuberculosis In Children
Anti Retroviral Therapy (NRT)
Asthma • Bronchiolitis • COPD
International Antimicrobial Stewardship & IPC
Intervention Recording/Feedback survey
Animal Health
Other National resources
Back to the top
